Pedram Argani
Department of Pathology
The Johns Hopkins Medical Institutions
Baltimore
MD 21231-2410
USA
Name/email consistency: high
- Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. Argani, P., Hicks, J., De Marzo, A.M., Albadine, R., Illei, P.B., Ladanyi, M., Reuter, V.E., Netto, G.J. Am. J. Surg. Pathol. (2010)
- A distinctive subset of PEComas harbors TFE3 gene fusions. Argani, P., Aulmann, S., Illei, P.B., Netto, G.J., Ro, J., Cho, H.Y., Dogan, S., Ladanyi, M., Martignoni, G., Goldblum, J.R., Weiss, S.W. Am. J. Surg. Pathol. (2010)
- Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Argani, P., Aulmann, S., Karanjawala, Z., Fraser, R.B., Ladanyi, M., Rodriguez, M.M. Am. J. Surg. Pathol. (2009)
- Papillary renal cell carcinoma with low-grade spindle cell foci: a mimic of mucinous tubular and spindle cell carcinoma. Argani, P., Netto, G.J., Parwani, A.V. Am. J. Surg. Pathol. (2008)
- Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Argani, P., Olgac, S., Tickoo, S.K., Goldfischer, M., Moch, H., Chan, D.Y., Eble, J.N., Bonsib, S.M., Jimeno, M., Lloreta, J., Billis, A., Hicks, J., De Marzo, A.M., Reuter, V.E., Ladanyi, M. Am. J. Surg. Pathol. (2007)
- Translocation carcinomas of the kidney. Argani, P., Ladanyi, M. Clin. Lab. Med. (2005)
- Metanephric neoplasms: the hyperdifferentiated, benign end of the Wilms tumor spectrum?. Argani, P. Clin. Lab. Med. (2005)
- Recent advances in pediatric renal neoplasia. Argani, P., Ladanyi, M. Adv. Anat. Pathol (2003)
- Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. Argani, P., Ladanyi, M. Pathology (2003)
- PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Argani, P., Antonescu, C.R., Couturier, J., Fournet, J.C., Sciot, R., Debiec-Rychter, M., Hutchinson, B., Reuter, V.E., Boccon-Gibod, L., Timmons, C., Hafez, N., Ladanyi, M. Am. J. Surg. Pathol. (2002)
- Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani, P., Shaukat, A., Kaushal, M., Wilentz, R.E., Su, G.H., Sohn, T.A., Yeo, C.J., Cameron, J.L., Kern, S.E., Hruban, R.H. Cancer (2001)
- Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Argani, P., Rosty, C., Reiter, R.E., Wilentz, R.E., Murugesan, S.R., Leach, S.D., Ryu, B., Skinner, H.G., Goggins, M., Jaffee, E.M., Yeo, C.J., Cameron, J.L., Kern, S.E., Hruban, R.H. Cancer Res. (2001)
- Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Argani, P., Antonescu, C.R., Illei, P.B., Lui, M.Y., Timmons, C.F., Newbury, R., Reuter, V.E., Garvin, A.J., Perez-Atayde, A.R., Fletcher, J.A., Beckwith, J.B., Bridge, J.A., Ladanyi, M. Am. J. Pathol. (2001)
- Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Argani, P., Iacobuzio-Donahue, C., Ryu, B., Rosty, C., Goggins, M., Wilentz, R.E., Murugesan, S.R., Leach, S.D., Jaffee, E., Yeo, C.J., Cameron, J.L., Kern, S.E., Hruban, R.H. Clin. Cancer Res. (2001)